COVID-19
A study published in Pediatric Allergy Immunology and Pulmonology has found that the COVID-19 pandemic significantly affected respiratory care in pediatric long-term care facilities (pLTCFs). Researchers at the University of Louisville conducted a retrospective study of 76 residents' oxygen, albuterol, hypertonic saline (HTS), and pulmonary hygiene treatment use from
COVID-19
A recent study published in the JMIR Nursing journal has shed light on the impact of burnout among health care workers during the COVID-19 pandemic. The research, conducted by a team of experts from the University of Wisconsin Milwaukee, found that burnout is not only affecting the well-being of health
COVID-19
A recent study published in the BMC Infectious Diseases journal has investigated the epidemiological characteristics of pediatric respiratory pathogens in Guangzhou, China, from 2018 to 2023, in the context of the COVID-19 pandemic. The research aimed to evaluate the impact of non-pharmaceutical interventions (NPIs) on the transmission dynamics and seasonal
COVID-19
A recent study published in The Journal of Infection in Developing Countries has revealed the impact of the COVID-19 pandemic on the detection rate of common pathogens causing acute respiratory infections (ARI) in children aged 6 years or younger in Wuhan, China. The research, conducted by a team of scientists
COVID-19
New research from the University of Ottawa has shed light on significant racial disparities in pediatric COVID-19 vaccine uptake in Canada. The study, published in the journal Vaccine, found that COVID-19 vaccination coverage among children of Black and Arab parents was substantially lower than among children of White and Asian
COVID-19
New research from the Silesian University of Technology in Poland has found that selective serotonin reuptake inhibitors (SSRIs), commonly prescribed for depression, pose significant environmental risks after the COVID-19 pandemic. The study assessed the environmental occurrence and ecological risks of SSRIs, including citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline, and found
COVID-19
Research published in the journal Medicine has found that pharmaceutical care provided by clinical pharmacists improves the clinical cure rate for heart transplant patients infected with COVID-19. The study, conducted in Wuhan, China, involved three heart transplant recipients who tested positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) nucleic acid.
COVID-19
A study conducted by researchers at Hiroshima University has shed light on the experiences of Filipino migrant domestic workers in Belgium, particularly in the context of the COVID-19 pandemic. The research utilizes a unique approach, exploring the intersection of biological citizenship and the black economy, and challenges traditional norms of
COVID-19
Research conducted by the National Academy of Sciences of Ukraine has yielded promising results in the development of new inhibitors against the SARS-CoV-2 virus. The study employed a multitask machine learning approach to evaluate the antiviral effectiveness of different chemical compounds against the main protease (M) of the virus. The
COVID-19
New research published in the Journal of Infection and Chemotherapy has found that booster vaccination significantly reduces the risk of oxygen deterioration in COVID-19 patients, particularly those with comorbidities. The study, conducted by researchers at the Nagoya University Graduate School of Medicine in Japan, analyzed data from 596 hospitalized mild-to-moderate
COVID-19
Research conducted at the Instituto Conmemorativo Gorgas de Estudios de la Salud has shed light on the potential use of antimalarial compounds in treating COVID-19. The study evaluated the antiviral activity of 26 compounds against the Delta and A2.5 variants of SARS-CoV-2, isolated in Panama between 2020 and 2022.
COVID-19
South Korea-based vaccine and biotech company SK bioscience has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) for a Phase 1/2 clinical trial of a new influenza vaccine candidate, NBP607B. This candidate incorporates an adjuvant into its existing cell-based influenza vaccine,
